Analyst picks & changes

Amgen Inc.


Genentech Inc.


Cowen & Co. analyst Joyce Lonergan said the start of clinical trials of thrombopoietin to boost platelets underscores AMGN's development expertise — cloning of TPO was announced only eight

Read the full 351 word article

How to gain access

Continue reading with a
two-week free trial.